Member Info for Owl11

Great news, should provide confidence to nervous investors.

Apologies, not my intention to mislead.

https://twitter.com/AIMdective/status/1466334963876442113?s=20

Very unlikely but wondered if others had alternative view.

I've read several people provide theories that last Patient RNS could have been released 14 days after the final dose, allowing for the time period patient can drop out of trial.

This of course would potentially move us 2 weeks closer to read out than anticipated.

Apologies if this has already been discussed (I've not seen it)

It's all well and good getting the vaccines approved relative to varients, but the logistics of then getting them into arms and time scales involved will be considerable, suspect uptake will continue to decrease also.

Tomorrow brings us to the month which should be the biggest in Synairgens history and within 2 weeks of receiving P3 data internally. Who knows if read out will be late December or early January, it matters not. However the fact it could be within the calendar month from tomorrow just reaffirms how close we now are.

Great find, hopefully the majority of our P3 recruits were infected with Delta variant.

https://bidstats.uk/tenders/2021/W46/763035774

Yet another de-risk for my investment. Recruitment is now fully completed, no ifs or buts to ponder.

Fantastic news, we really are on the home straight, really interested to see the long covid data, potentially that could stand us apart further.

Impatient to the patient etc etc

They know it!

Reassuring for those that need it.

Those waiting to top up, this is your window.

What did he/she say Johbar?

Closed bang on £2 according to Google.

If you believe that our P3 results will be significant then the current price is an absolute bargain.

Always up for a party, count me in!

I agree, and suspect the sp will continue to grow. I was saying yesterday it doesn't make sense for sp to be flat prior to a anticipated rise in the multiples, too much of a gap.

£2 or not its been an amazing week and suspect we will continue to rise as anticipation grows.